Gilead Sciences Inc (GILD)
92.11
-0.52
(-0.56%)
USD |
NASDAQ |
Nov 14, 16:00
92.12
+0.01
(+0.01%)
After-Hours: 20:00
Gilead Sciences Cash and Short Term Investments (Quarterly): 5.037B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.037B |
| June 30, 2024 | 2.772B |
| March 31, 2024 | 4.718B |
| December 31, 2023 | 7.264B |
| September 30, 2023 | 6.864B |
| June 30, 2023 | 6.667B |
| March 31, 2023 | 5.872B |
| December 31, 2022 | 6.385B |
| September 30, 2022 | 5.66B |
| June 30, 2022 | 5.663B |
| March 31, 2022 | 5.325B |
| December 31, 2021 | 6.52B |
| September 30, 2021 | 5.738B |
| June 30, 2021 | 6.525B |
| March 31, 2021 | 5.666B |
| December 31, 2020 | 7.408B |
| September 30, 2020 | 23.98B |
| June 30, 2020 | 18.91B |
| March 31, 2020 | 20.78B |
| December 31, 2019 | 24.35B |
| September 30, 2019 | 22.86B |
| June 30, 2019 | 27.18B |
| March 31, 2019 | 27.90B |
| December 31, 2018 | 30.09B |
| September 30, 2018 | 28.47B |
| Date | Value |
|---|---|
| June 30, 2018 | 25.92B |
| March 31, 2018 | 24.00B |
| December 31, 2017 | 25.51B |
| September 30, 2017 | 28.39B |
| June 30, 2017 | 21.10B |
| March 31, 2017 | 14.12B |
| December 31, 2016 | 11.90B |
| September 30, 2016 | 12.27B |
| June 30, 2016 | 8.752B |
| March 31, 2016 | 8.319B |
| December 31, 2015 | 14.61B |
| September 30, 2015 | 15.71B |
| June 30, 2015 | 8.611B |
| March 31, 2015 | 11.29B |
| December 31, 2014 | 10.13B |
| September 30, 2014 | 6.316B |
| June 30, 2014 | 8.799B |
| March 31, 2014 | 6.469B |
| December 31, 2013 | 2.132B |
| September 30, 2013 | 2.090B |
| June 30, 2013 | 2.287B |
| March 31, 2013 | 1.943B |
| December 31, 2012 | 1.862B |
| September 30, 2012 | 1.695B |
| June 30, 2012 | 1.708B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.772B
Minimum
Jun 2024
24.35B
Maximum
Dec 2019
9.106B
Average
6.452B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly and Co | 3.518B |
| Merck & Co Inc | 14.59B |
| Vertex Pharmaceuticals Inc | 6.524B |
| Amgen Inc | 9.011B |
| Pfizer Inc | 9.952B |